$AMRN News Article - European Medicines Agency Accepts for Review Marketing Authorization Application for Amarin's Icosapent Ethyl (Vascepa ) for Reduction of Cardiovascular Risk in High-Risk Patients, as Reflected in REDUCE-IT Study https://marketwirenews.com/news-releases/euro...49676.html